The recombination activating gene, RAG-1, which is supposed to encode a molecule regulating V(D)J recombination, has been isolated. In the current study, the distribution of RAG-1 expression in human neoplastic hematopoietic cells was compared with the phenotypic and genotypic status of differentiation. Thirty-one hematopoietic cell lines (1 6 B-lineage, 9 T-lineage, 2 Hodgkin's disease, and 4 nonlymphoid cell lines) were investigated for the expression of human RAG-1 using the reverse-transcriptase polymerase chain reaction (RT-PCR). RAG-1 was not expressed in nonlymphoid, Hodgkin's disease, or mature-stage lymphoid cell lines, but was present in some acute lymphoblastic leukemia (ALL)/lymphoblastic lymphoma (LBL) cell lines. The investigation was extended to 45 cases of fresh ALL/LBL cells. The patterns of RAG-1 expression found in the cell lines and fresh ALL/LBL cells were similar. In B-lineage cells, the product of RAG-1 RT-PCR was detected in CD19+ CD10-CD20-CD5-stage (stage II, Nadler's classification) and was at the highest level in CD19+ CD1 O+ CD20-CD5-stage (stage Ill), but was absent or limited in CD19+ CD10' CD20+ CD5-(stage IV) or CD19+ CDI O+ (or CD1 0 -) CD5'. In stage II, monoclonal gene rearrangements of only the immunoglobulin heavy chain (IgH) were found, whereas monoclonal HE VAST diversity of the immune repertoire exhibited
T by T-cell receptor (TCR) and immunoglobulin (Ig) is
initially acquired by gene rearrangement of Ig and TCR during the early stages of lymphoid differentiation, referred to as V(D)J recombination, and in the Ig gene, by further class switch recombination and hypermutation.' Based on this fundamental understanding, monoclonal gene rearrangements of TCR and Ig have been detected in human neoplastic hematopoietic cells, and the clonality, lineage, and stage of differentiati~n'.~ has been determined. Such studies helped clarify the classification of human neoplastic hematopoietic cells and the differentiation schemes of normal hematopoiesis, which had been delineated by detecting antigens with numerous monoclonal antibodies. However, the monoclonally rearranged gene structures of TCR or Ig found in neoplastic lymphoid cells are the products of recombination mechanisms, and whether TCR or Ig genes are rearranged is essentially different from the issue of whether recombination activity occurs.
Murine studies have shown that the rearrangements of endogenous gene loci or exogenously induced substrates for recombination occurs in only T-and B-cell lines at immature stage^.^-^ In studies with human leukemia/lymphoma cells, monoclonal rearrangements of the TCR or Ig genes have been found in the immature cells with very scarce antigens for lineage determination, and the gene rearrangement of both TCR and Ig, referred to as a dual genotype, has also been recorded in some immature cells.'~* These observations suggest the presence of a common recombinase for both T and B lineage.G Schatz et al' and Oettinger et all0 isolated two genes that gene rearrangements of both IgH and T-cell receptor (TCR)-@ chain were frequently noted in stages Ill and IV. The expression of CD20 or CD5 antigen apparently correlated with the decline of RAG-1 expression. In T-lineage cells, RAG-1 was highly expressed in CD3-CD4+ CD8+/ CD3+ CD4+ CD8+ thymic stages, but was negative or only weakly expressed in the CD3-CD4-CD8-prothymic or early thymic stage, in which the TCR-@ gene was often germline, or the CD3+ CD4+ CD8-mature thymic stage. The relative levels of RAG-1 mRNA give an additional delineating frame to the schemes of lymphoid differentiation based on phenotypic and genotypic status. RAG-1 is exhibited by cells of the thymic stage capable of synthesizing TCR or expressing it on the cell surface. The weak or absent expression of RAG-1 in the prothymic or early thymic stage suggests that the contribution of RAG-I to the gene rearrangement may differ quantitatively between TCR-G/TCR-r and TCR-@. Unlike the minimal or absent expression of RAG-I mRNA in the prothymic or early thymic stage, the most immature observable stage of Blineage cells had RAG-I mRNA, suggesting that the regulation of RAG-1 expression may differ between T-and B-lineage cells. activate V(D)J recombination, RAG-I and RAG-2. The experiments using RAG-1-transfected fibroblasts showed that RAG-1 alone could induce some activity ofgene recombination,' whereas the experiments using the gene-targeted mice for RAG-1 or RAG-2 showed that both RAG-1 and RAG-2 are indispensable for the V(D)J recombination'','* of the lymphoid system in the mice. Whether RAG-I and RAG-2 have enzymatic activity in cleaving DNA has not been determined. The exact distribution of the expression of human RAG-I and RAG-2 genes has not been investigated among human hematopoietic cells, particularly in association with the phenotypic and genotypic status. As a first step to determine the distribution of recombination activity. we tested 31 human hematopoietic cell lines and 45 cases of fresh neoplastic hematopoietic cells for the expression of human RAG-I gene using reverse-transcriptase polymerase chain reaction (RT-PCR). and analyzed cell surface antigen expression and gene rearrangement. The results showed that RAG-I is expressed in a stage-specific manner among acute lymphoblastic leukemia (ALL)/lymphoblastic lymphoma (LBL) cells.
MATERIALS AND METHODS
Cid//btc.s. RAG-I expression was investigated in 3 I human hematopoietic cell lines at various stages of lymphoid and non-lymphoid lineages using RT-PCR. These included P30/0hkubo. UddXX. Tahr87, KM3. Reh. MOLTIO. NALM6. NALMlh. KLMZ. HPR-NULL. and NALM I (derived from hlastic c chronic myeloid leukemia). which are pre-R ALLcellslsl': R ER3. Rurkitt Cell surface Ig was detected with FITC-conjugated antihuman n. y, p. 6. K. X goat IgG F(ab')2 fragment (Tago, Burlingame. CA) aner adding heat aggregated bovine y globulin (20 mg/mL) (Sigma. St Louis. MO) for blocking Fc receptor.
Incubation was for 30 minutes at 4°C. The stained cells were assayed with a n EPICS-C flow cytometer (Coulter).
Terminal deir\-!nrr:lbcli~i#ic!l.l trunsferu.w (TdT). The expression of T d T was investigated by Northern blot analysis*' using the total RNA extracted" from the ALL/LRL cell lines and the human T d T cDNA ( I 104h EcoRI fragment). supplied by Dr Koiwai (Aichi Cancer Center. Nagoya. Japan)." as probe in the ALL/LBL cell lines. Indirect immunofluorescence with rabbit antihuman T d T
NUT3(CD3). NUT-H/I(CW). NUT-PAN(CD5). NUT-S/C(CDX).
For personal use only. Northern blot analysis. Total RNA was extracted from the pellets of the cell lines with the cesium chloride centrifugation method.26 The Northern blot analysis for TdT was performed by using the total RNA. Thirty micrograms of total RNA was size fractionated on I .O% agarose gel, and transferred to Gene Screen Plus nylon membranes (New England Nuclear, Boston, MA). The filters were hybridized with the TdT probe that was labeled with [a-"P]dCTP by random priming method. After hybridization, the membranes were washed at an appropriate stringency and autoradiographed. Poly(A)* RNA was extracted from the total RNA of Udd88, KM3, NALM6, and HPB-NULL with oligo-dT-conjugated latex beads (Ohgotex-dT30 Super; Takara, Kyoto, Japan) according to the manufacturer's protocol. Five micrograms of the poly(A)+ RNA of each cell line was loaded in Northern blot analysis. A 0.9-kb Xho I-Hind111 fragment of human RAG-1 cDNA, which was supplied by Dr Schatz (Yale University School of Medicine, New Haven, CT),9 was used as probe.
Southern blot analysis. High molecular weight DNA was extracted from the frozen pelleted blasts as d e s~r i b e d .~~~~~
Ten micrograms of DNA was digested with EcoRI, BamHI, or Hind111 (Takara, Kyoto, Japan) restriction endonuclease. The restriction fragments were size fractionated on 0.7% agarose gels and transferred to Gene Screen Plus nylon membranes. The filters were hybridized with the probes that were labeled with [a-"P]dCTP by nick translation. After hybridization, the membranes were washed at an appropriate stringency, and autoradiographed. To analyze the gene rearrangement of the TCR-/3 chain, the EcoRI, BamHI, or Hind111 digests were hybridized with the Cp probe, a 3. For personal use only. on November 11, 2017 . by guest www.bloodjournal.org From Control &actin mRNA3* was also amplified by the same procedure to ensure the quality of the mRNA and the amount of cDNA in each sample. Two sequences, spanning two introns. S'GAAATCGTGCGTGACATTAAG 3' (bp I 192-I2 12) and SCTAGAAGCATTTGCGGTGGACGATGGAGGGGCCT (hp 1908-1 94 I ), were adopted as sense and anti-sense primers. respectively. The conditions for PCR were 30 cyclesconsisting ofdenaturation at 94°C for 60 seconds, annealingat 6 I "C for 60 seconds, and extension at 72°C for 60 seconds.
Qrianrirarion ?/RAG'-I rxprersion risinz dot hlor. A problem in RT-PCR with clinical samples was the possible contamination of normal RAG-I + bone marrow cells. To determine the least detectable number of contaminating normal RAG-I + cells. RAG-I expression was quantified by mixing a RAG-I high-expressing pre-R line (KM3) and a RAG-I nonexpressing myeloid line (ML3). from which the same amount of total RNA was obtained on a per-cell basis. RT-PCR was performed with the KM3 cells diluted IO-' to IO-' with ML3 cells. One and two percent ofeach of the products were spotted onto nylon membranes. and the dots were hybridized with internal oligonucleotide probes end-labeled with [y-"P]dATP by T4-polynucleotide kinase. Internal probes for RAG-I and 8-actin were S'GCAAGAGGCAAAGCGATCCAT and S'ACCTTC-CAGCAGATGTGGATT, respectively. After washing. dots were exposed for 2 hours at -80°C. The density of each autoradiographed dot (see Fig 2) was quantified by a computingdensitometer (Molecular Dynamics, Sunnyvale, CA), and the ratio of the density of RAG-I to 8-actin (R/S ratio) was calculated in each ofthe KM3 samples diluted with ML3. According to the results ofthe cell-mixing study and the probable degree of the contamination of nonneoplastic cells, a grading was established. CT) was added to 10 pL of the RT reaction mixture. The mixture was amplified using thermal cycler (Iwaki, Tokyo. Japan) for 32 cycles consisting of denaturation at 94°C for 60 seconds. annealing at 60°C for 60 seconds. and extension at 72°C for 90 seconds. Fifteen microliters of PCR products was electrophoresed through a 3% NuSieve agarose gel (FMC Rioproducts, Rockland. ME) and visualized with ethidium bromide. In addition. toconfirm thespecificity of the RT-PCR products. they were transferred to nylon To compare the sensitivity of RT-PCR with conventional Northern blotting, poly(A)+ RNA was extracted from the Udd88, KM3, NALM6, and HPB-NULL cells. As shown in Fig 1 D , no signal was detected in Udd88, suggesting that the degree of RAG-I expression by Udd88 is detectable with RT-PCR, but not in Northern blot analysis.
RESULTS

MG
The results of the gene rearrangement of IgH and TCR-0, the Northern blot study of TdT, cell-surface antigen analysis and RAG-1 expression are summarized in Tables 1 and  2 . Among B-lineage cells, 6 of 9 cell lines of RAG-1 highstage 111 and RAG-1 low-or negative-stage IV were of dual genotype, whereas 2 of the 2 cell lines of RAG-1 low-stage I1 were of a rearranged genotype for IgH alone. One of the seven T-ALL/LBL cell lines is of dual genotype.
Quantitation of RAG-I expression using dot blots.
When applying the RT-PCR method to clinical samples, contaminating normal bone marrow cells expressing RAG-I may cause false positivity, because the RT-PCR product of RAG-I was undetectable in PBMC but detectable in normal bone marrow cells (data not shown). To overcome the problem, PBMC samples containing 90% or more blasts were selected and a grading was established for clinical samples.
As shown in Fig 2A when logarithmically diluting the KM3 (RAG-1 +) with the ML3 (RAG-1 -) cells, the RT-PCR product of RAG-1 was detectable at lo-' dilution but not at and dilutions by ethidium bromide staining. Therefore, one to a few percent of contaminating RAG-I + cells can cause positivity (Fig 2) . When RT-PCR of 35 or more cycles were performed in acute myeloid leukemia (AML) samples, products with the same density as that of the 10-3-diluted KM3 cells appeared (data not shown), indicating that 35 cycles RT-PCR was so sensitive as to show the RAG-1 mRNA of contaminating normal cells. Thus, RT-PCR was performed at 32 cycles.
The RT-PCR products spotted on nylon membranes and hybridized with 32P-labeled oligonucleotide probe for RAG-1 or &actin (Fig 2B) were quantified with the densitometer. The ratio of the density of RAG-I/P-actin (RIP ratio) represented the index of RAG-I expression (Table 3) . Based on the results of the cell-mixing study and three cases of AML (0.009,0.026,0.06 1) and the probable degree ofthe contamination of non-neoplastic cells, a grading was set as follows;
to 0.500; +++, 0.500<.
The arbitrary grade of band density of RT-PCR product stained with ethidium bromide, RIP ratio of dot, the grading of RIP ratio, TdT expression and the gene rearrangement of IgH, TCR-6, TCR-7, and TCR-/3 are shown in Tables 4 and 5 .
All pre-B ALL cases except for one stage I1 (Nadler et aI3') and one stage IV were graded as + or higher in terms of RIP ratio, as shown in Fig 3 and Table 4 . The Southern blot analysis by using an oligonucleotide probe specific for RAG-1 confirmed the specificity of the RT-PCR products, as shown in Fig 3A. TdT was positive in all samples tested. CD8-or more immature) cases were -or f, whereas 3 cases (patients 3, 4, and 10) were + or ++, as shown in Fig 4 and Table 5 . In contrast, all thymic (CD3-CD4+ CD8+/CD3+ CD4+ CD8') T-ALL/LBL cases were strongly positive (+++)for RAG-1 transcript except for patients 15 (++)and 16 (+). A mature thymic case (patient 22) was +. TdT was negative in 9 of 14 cases of prothymic or early thymic stage, whereas patients 6, 8, 10, and 13 were positive. The gene configuration of both TCR-P and IgH was germline in the prothymic or early thymic stage except for patients 10 (++) and 13 (-) . The specificity of the RT-PCR products was confirmed by the Southern blot analysis, as shown in Fig  4A. All samples at the thymic stage had monoclonal gene rearrangement of TCR-P. Dual gene rearrangement was noted in only 2 of the 7 thymic cases. Among the 12 fresh T-lineage ALL/LBL patient samples with the germline gene of TCR-P, 3 were of the germline gene for both TCR-6 and TCR-7,6 of the rearranged gene for TCR-6 alone, and 3 for both TCR-6 and TCR-7. All CD3+ blasts were TCR-1 + and TCR-61-except for patient 22, who was TCR-I-and TCR-61+. CD13 antigen was expressed in cells from patients 2,5,8, 12, and 13, and CD33 antigen was expressed in cells from patients 1, 2, 4, 5 , and 12. rearrangement analysis in our study led to the different results, which were not pointed out in their report. The methodological differences in RT-PCR included the primer for reversed single-stranded cDNA synthesis (random hexamer versus specific primers) and the setting of the primers for PCR (the sequences spanning the intron versus the sequences within the exon). Their methods for both ofthe two steps may have possibly increased the RT-PCR products.
RAG-I was ++ or +++ in 6 of 7 thymic stage cases. This high expression at the thymic stage was not necessarily expected, if based on a former recognition that RAG-1 expression should no longer be necessary after synthesizing TCR or expressing it on the cell surface. Turka et aI4* have already reported that the TCR cross-linking of normal murine cortical thymocytes suppressed their RAG-1 and RAG-2 expression. High RAG-I expression may be one ofthe majorcharacteristics camed by normal and neoplastic cells at the thymic stage. RAG-1 was -or * in 11 of 14 prothymic or early thymic cell cases. TCR-8 gene was of germline in 1 1 of the 12 prothymic or early thymic RAG-1-or 2 cases. Among these 1 1 cases, 3 were ofentire germline and 8 had a monoclonal gene rearrangement of the TCR-6 alone or of the TCR-6 and TCR-y. Thus, the contribution of RAG-1 to the gene rearrangement of TCR-6 and TCR-y seems to be limited or quantitatively different compared with that of TCR-P. However, it is possible that the limited expression of RAG-1 does play a role for the gene rearrangement of
TCRd and TCR-y in those T-ALL/LBL cases of prothymic
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